TY - JOUR AB - Cancer remains the one of the most common causes of mortality in humans; thus, cancer treatment is currently a major focus of investigation. Researchers worldwide have been searching for the optimal treatment (the ‘magic bullet’) that will selectively target cancer, without afflicting significant morbidity. Recent advances in cancer nanotechnology have raised exciting opportunities for specific drug delivery by an emerging class of nanotherapeutics that may be targeted to neoplastic cells, thereby offering a major advantage over conventional chemotherapeutic agents. There are two ways by which targeting of nanoparticles may be achieved, namely passive and active targeting. The aim of this study was to provide a comprehensive review of the literature focusing on passive targeting. AD - Department of Otorhinolaryngology, Faculty of Medicine, Alexandria University, Alexandria 21131, Egypt Department of Ophthalmology, Faculty of Medicine, Beirut Arab University, Beirut 1107 2809, Lebanon Department of Pathology, Faculty of Medicine, Alexandria University, Alexandria 21131, Egypt Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Alexandria University, Alexandria 21131, Egypt AU - Bazak,Remon AU - Houri,Mohamad AU - El Achy,Samar AU - Hussein,Wael AU - Refaat,Tamer DA - 2014/11/01 DO - 10.3892/mco.2014.356 EP - 908 IS - 6 JO - Mol Clin Oncol KW - nanoparticles cancer passive targeting PY - 2014 SN - 2049-9450 2049-9469 SP - 904 ST - Passive targeting of nanoparticles to cancer: A comprehensive review of the literature T2 - Molecular and Clinical Oncology TI - Passive targeting of nanoparticles to cancer: A comprehensive review of the literature UR - https://doi.org/10.3892/mco.2014.356 VL - 2 ER -